Advertisement

The Scientist

» clinical trials

Most Recent

image: UCSD Names New Head of Alzheimer’s Study

UCSD Names New Head of Alzheimer’s Study

By | January 18, 2016

The project at the center of the dust up between the University of California, San Diego, and the University of Southern California gets a new leader, as the institutions continue to battle in court.

0 Comments

image: TS Picks: December 30, 2015

TS Picks: December 30, 2015

By | December 30, 2015

Overvaluing startups; undervaluing human research participants; curing aging?

0 Comments

image: Stem Cell Biologist Dies

Stem Cell Biologist Dies

By | November 23, 2015

Paolo Bianco crusaded against cell therapy fraud and hype.

0 Comments

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Oncologist Found Guilty of Misconduct

Oncologist Found Guilty of Misconduct

By | November 9, 2015

A government investigation concludes that Anil Potti faked data on multiple grants and papers.

3 Comments

Some antibodies designed to eliminate the plaques prominent in Alzheimer’s disease can aggravate neuronal hyperactivity in mice.

1 Comment

image: Latest in Heart Stem Cell Debate

Latest in Heart Stem Cell Debate

By | October 26, 2015

Given the right environment, cKit+ cells from the mouse heart can develop into new cardiac muscle, according to a study.

0 Comments

image: Duke Cardiologist Tapped to Lead FDA

Duke Cardiologist Tapped to Lead FDA

By | September 17, 2015

The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.

0 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. A Scrambled Mess
    Features A Scrambled Mess

    Why do so many human eggs have the wrong number of chromosomes?

Advertisement
Diagenode
Diagenode
Advertisement
RayBioTech